Compare SCLX & CLPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCLX | CLPR |
|---|---|---|
| Founded | 2011 | 2015 |
| Country | United States | United States |
| Employees | 34 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.5M | 46.4M |
| IPO Year | N/A | 2015 |
| Metric | SCLX | CLPR |
|---|---|---|
| Price | $9.43 | $2.85 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 118.9K | ★ 169.2K |
| Earning Date | 04-10-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 10.73% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $109,997,000.00 |
| Revenue This Year | $122.52 | N/A |
| Revenue Next Year | $186.30 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.82 |
| 52 Week Low | $4.20 | $2.69 |
| 52 Week High | $34.27 | $4.61 |
| Indicator | SCLX | CLPR |
|---|---|---|
| Relative Strength Index (RSI) | 61.25 | 40.48 |
| Support Level | $7.73 | $2.81 |
| Resistance Level | $9.44 | $3.28 |
| Average True Range (ATR) | 0.97 | 0.16 |
| MACD | 0.24 | -0.02 |
| Stochastic Oscillator | 75.84 | 23.64 |
Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.